AUS
NZ
UK
CA
USA
IND
Highlights
- Institutional firms control 95.91% of Perrigo Company plc.
- Financial firms revised ratings, adjusting price targets.
- Perrigo reported stable earnings per share despite a slight revenue decline.
Perrigo Company PLC is part of NYSE Healthcare Stocks and remains active in the self-care and over-the-counter health market. Institutional firms hold a significant portion of its stock, with recent financial adjustments reflecting shifts in market positioning. Despite a slight revenue decline, the company reported stable earnings per share, reinforcing its presence in the healthcare sector.
Institutional Participation and Market Activity
Perrigo Company plc (NYSE:PRGO) has seen consistent engagement from financial firms. SG Americas Securities LLC entered a new position in the company during the fourth quarter, acquiring 26,868 shares.
Other financial firms, including Versant Capital Management Inc., GAMMA Investing LLC, Central Pacific Bank Trust Division, Venturi Wealth Management LLC, and KBC Group NV, have also adjusted their stakes in recent quarters. These moves highlight continued activity surrounding the company’s market position.
Stock Transactions and Leadership Adjustments
Recent stock transactions within Perrigo include movements from leadership figures. Director Jeffrey B. Kindler completed a transaction involving 17,598 shares, valued at $497,495.46. Following this, retained shares stood at 5,409, representing a fractional portion of total company shares.
Overall, leadership transactions account for 0.70% of total shares. These adjustments contribute to market sentiment and reflect broader financial planning within the company.
Stock Ratings and Market Sentiment
Perrigo has received revised ratings from financial firms. Some firms adjusted their ratings, modifying price targets in response to company performance trends. The latest target price is set at $35, with mixed perspectives on stock movement.
These adjustments reflect shifts in market sentiment, aligning with broader industry developments. Financial firms continue to evaluate stock movements based on company performance and strategic direction.
Financial Performance and Market Trends
Perrigo opened trading at $24.90, with a market capitalization of $3.40 billion. The stock has fluctuated between a 12-month low of $23.14 and a high of $33.46.
Earnings per share for the last quarter stood at $0.81, in line with financial projections. Revenue declined by 3.2% from the previous year, reflecting adjustments in business performance. Fiscal year estimates indicate potential changes based on company initiatives and market positioning.
Business Operations and Industry Presence
Perrigo specializes in over-the-counter health and wellness products, operating across the United States, Europe, and international markets. The company manages two key divisions: Consumer Self-Care Americas and Consumer Self-Care International.
Product lines include respiratory treatments, nutritional supplements, and oral care solutions. By maintaining a presence in self-care markets, Perrigo continues to expand its product offerings and market engagement.
Perrigo Company plc maintains significant institutional participation, leadership stock transactions, and adjusted financial ratings. While earnings remain stable, revenue shifts and market sentiment continue to influence stock performance. The company remains engaged in self-care product development, positioning itself within a competitive healthcare market.
